1
|
Raj A, Allababidi A, Kayed H, Gerken ALH, Müller J, Schoenberg SO, Zöllner FG, Rink JS. Streamlining Acute Abdominal Aortic Dissection Management-An AI-based CT Imaging Workflow. JOURNAL OF IMAGING INFORMATICS IN MEDICINE 2024:10.1007/s10278-024-01164-0. [PMID: 38864947 DOI: 10.1007/s10278-024-01164-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/23/2024] [Revised: 05/24/2024] [Accepted: 06/04/2024] [Indexed: 06/13/2024]
Abstract
Life-threatening acute aortic dissection (AD) demands timely diagnosis for effective intervention. To streamline intrahospital workflows, automated detection of AD in abdominal computed tomography (CT) scans seems useful to assist humans. We aimed at creating a robust convolutional neural network (CNN)-based pipeline capable of real-time screening for signs of abdominal AD in CT. In this retrospective study, abdominal CT data from AD patients presenting with AD and from non-AD patients were collected (n 195, AD cases 94, mean age 65.9 years, female ratio 35.8%). A CNN-based algorithm was developed with the goal of enabling a robust, automated, and highly sensitive detection of abdominal AD. Two sets from internal (n = 32, AD cases 16) and external sources (n = 1189, AD cases 100) were procured for validation. The abdominal region was extracted, followed by the automatic isolation of the aorta region of interest (ROI) and highlighting of the membrane via edge extraction, followed by classification of the aortic ROI as dissected/healthy. A fivefold cross-validation was employed on the internal set, and an ensemble of the 5 trained models was used to predict the internal and external validation set. Evaluation metrics included receiver operating characteristic curve (AUC) and balanced accuracy. The AUC, balanced accuracy, and sensitivity scores of the internal dataset were 0.932 (CI 0.891-0.963), 0.860, and 0.885, respectively. For the internal validation dataset, the AUC, balanced accuracy, and sensitivity scores were 0.887 (CI 0.732-0.988), 0.781, and 0.875, respectively. Furthermore, for the external validation dataset, AUC, balanced accuracy, and sensitivity scores were 0.993 (CI 0.918-0.994), 0.933, and 1.000, respectively. The proposed automated pipeline could assist humans in expediting acute aortic dissection management when integrated into clinical workflows.
Collapse
Affiliation(s)
- Anish Raj
- Computer Assisted Clinical Medicine, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167, Mannheim, Germany.
- Mannheim Institute for Intelligent Systems in Medicine, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167, Mannheim, Germany.
| | - Ahmad Allababidi
- Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Theodor-Kutzer-Ufer 1-3, D-68167, Mannheim, Germany
| | - Hany Kayed
- Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Theodor-Kutzer-Ufer 1-3, D-68167, Mannheim, Germany
| | - Andreas L H Gerken
- Department of Surgery, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167, Mannheim, Germany
| | - Julia Müller
- Mediri GmbH, Eppelheimer Straße 13, D-69115, Heidelberg, Germany
| | - Stefan O Schoenberg
- Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Theodor-Kutzer-Ufer 1-3, D-68167, Mannheim, Germany
| | - Frank G Zöllner
- Computer Assisted Clinical Medicine, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167, Mannheim, Germany
- Mannheim Institute for Intelligent Systems in Medicine, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167, Mannheim, Germany
| | - Johann S Rink
- Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Theodor-Kutzer-Ufer 1-3, D-68167, Mannheim, Germany
| |
Collapse
|
2
|
Wu M, Islam MM, Poly TN, Lin MC. Application of AI in Sepsis: Citation Network Analysis and Evidence Synthesis. Interact J Med Res 2024; 13:e54490. [PMID: 38621231 PMCID: PMC11058558 DOI: 10.2196/54490] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2023] [Revised: 01/27/2024] [Accepted: 03/04/2024] [Indexed: 04/17/2024] Open
Abstract
BACKGROUND Artificial intelligence (AI) has garnered considerable attention in the context of sepsis research, particularly in personalized diagnosis and treatment. Conducting a bibliometric analysis of existing publications can offer a broad overview of the field and identify current research trends and future research directions. OBJECTIVE The objective of this study is to leverage bibliometric data to provide a comprehensive overview of the application of AI in sepsis. METHODS We conducted a search in the Web of Science Core Collection database to identify relevant articles published in English until August 31, 2023. A predefined search strategy was used, evaluating titles, abstracts, and full texts as needed. We used the Bibliometrix and VOSviewer tools to visualize networks showcasing the co-occurrence of authors, research institutions, countries, citations, and keywords. RESULTS A total of 259 relevant articles published between 2014 and 2023 (until August) were identified. Over the past decade, the annual publication count has consistently risen. Leading journals in this domain include Critical Care Medicine (17/259, 6.6%), Frontiers in Medicine (17/259, 6.6%), and Scientific Reports (11/259, 4.2%). The United States (103/259, 39.8%), China (83/259, 32%), United Kingdom (14/259, 5.4%), and Taiwan (12/259, 4.6%) emerged as the most prolific countries in terms of publications. Notable institutions in this field include the University of California System, Emory University, and Harvard University. The key researchers working in this area include Ritankar Das, Chris Barton, and Rishikesan Kamaleswaran. Although the initial period witnessed a relatively low number of articles focused on AI applications for sepsis, there has been a significant surge in research within this area in recent years (2014-2023). CONCLUSIONS This comprehensive analysis provides valuable insights into AI-related research conducted in the field of sepsis, aiding health care policy makers and researchers in understanding the potential of AI and formulating effective research plans. Such analysis serves as a valuable resource for determining the advantages, sustainability, scope, and potential impact of AI models in sepsis.
Collapse
Affiliation(s)
- MeiJung Wu
- Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
- Department of Nursing, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
| | - Md Mohaimenul Islam
- Department of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH, United States
| | - Tahmina Nasrin Poly
- Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
| | - Ming-Chin Lin
- Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
- Taipei Neuroscience Institute, Taipei Medical University, Taipei, Taiwan
- Department of Neurosurgery, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan
| |
Collapse
|
3
|
Song JH, Tomihama RT, Roh D, Cabrera A, Dardik A, Kiang SC. Leveraging Artificial Intelligence to Optimize the Care of Peripheral Artery Disease Patients. Ann Vasc Surg 2024:S0890-5096(24)00143-2. [PMID: 38582202 DOI: 10.1016/j.avsg.2023.11.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2023] [Accepted: 11/23/2023] [Indexed: 04/08/2024]
Abstract
Peripheral artery disease is a major atherosclerotic disease that is associated with poor outcomes such as limb loss, cardiovascular morbidity, and death. Artificial intelligence (AI) has seen increasing integration in medicine, and its various applications can optimize the care of peripheral artery disease (PAD) patients in diagnosis, predicting patient outcomes, and imaging interpretation. In this review, we introduce various AI applications such as natural language processing, supervised machine learning, and deep learning, and we analyze the current literature in which these algorithms have been applied to PAD.
Collapse
Affiliation(s)
- Jee Hoon Song
- Division of Vascular Surgery, Department of Surgery, Linda University School of Medicine, Loma Linda, CA
| | - Roger T Tomihama
- Division of Vascular and Interventional Radiology, Department of Radiology, Linda University School of Medicine, Loma Linda, CA
| | - Daniel Roh
- Division of Vascular and Interventional Radiology, Department of Radiology, Linda University School of Medicine, Loma Linda, CA
| | - Andrew Cabrera
- Division of Vascular and Interventional Radiology, Department of Radiology, Linda University School of Medicine, Loma Linda, CA
| | - Alan Dardik
- Division of Vascular Surgery, Department of Surgery, Yale University School of Medicine, New Haven, CT
| | - Sharon C Kiang
- Division of Vascular Surgery, Department of Surgery, Linda University School of Medicine, Loma Linda, CA; Division of Vascular Surgery, Department of Surgery, VA Loma Linda Healthcare System, Loma Linda, CA.
| |
Collapse
|
4
|
Garza-Herrera R. Humans use tools: From handcrafted tools to artificial intelligence. J Vasc Surg Venous Lymphat Disord 2024; 12:101705. [PMID: 37956905 DOI: 10.1016/j.jvsv.2023.101705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Revised: 10/17/2023] [Accepted: 10/19/2023] [Indexed: 11/21/2023]
Abstract
Human evolution is instrument based. Humans created tools >2 million years ago to aid them in hunting, gathering, and defense, allowing them to build shelters and farms and transport goods and people over great distances. Written records preserved our knowledge and experiences for future generations. Instruments have greatly influenced surgery. Knives and needles were used by ancient surgeons, whereas lasers, endoscopes, and robotics are used today. Artificial intelligence (AI) is the future of surgical instruments, increasing precision through self-evaluation, but development remains in the early stages. Vascular surgery research and practice has used AI-powered systems that can track patient progress and identify vascular disease risk using deep learning and pattern recognition, as well as improved radiological interpretation of vascular imaging and medicine. Using insights and data-driven recommendations, AI-powered decision support systems could help surgeons in enhancing patient outcomes by providing guidance to navigate complex anatomy and identify anomalies. Robots can assist surgeons in performing risky, complex operations with optimal outcomes. Human expertise and AI will revolutionize surgery, enhancing its safety, precision, and efficacy. Surgical applications of AI raise numerous questions and debates. Data must be representative of all populations, data management must protect the privacy of patients and physicians, and the AI decision-making process must be clarified to produce validated models that can be used ethically. Vascular surgeons' judgment and experience should not be automated. Instead, AI should contribute to the efficiency and effectiveness of vascular surgeons. Human clinicians must interpret AI-generated data, use clinical judgment, and build empathy, compassion, and shared decision-making to sustain doctor-patient relationships. From simple tools to complex modern technologies, the history of tools reveals human creativity. Our environment has been altered by technology, ensuring our survival and growth. AI is still a half-told tale that will inspire and amaze us for years to come.
Collapse
Affiliation(s)
- Rodrigo Garza-Herrera
- Department of Vascular Surgery, Centro Multidisciplinario Healthy Steps, Morelia, Michoacán, México.
| |
Collapse
|
5
|
Li A, Javidan AP, Namazi B, Madani A, Forbes TL. Development of an Artificial Intelligence Tool for Intraoperative Guidance During Endovascular Abdominal Aortic Aneurysm Repair. Ann Vasc Surg 2024; 99:96-104. [PMID: 37914075 DOI: 10.1016/j.avsg.2023.08.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2023] [Revised: 08/02/2023] [Accepted: 08/15/2023] [Indexed: 11/03/2023]
Abstract
BACKGROUND Adverse events during surgery can occur in part due to errors in visual perception and judgment. Deep learning is a branch of artificial intelligence (AI) that has shown promise in providing real-time intraoperative guidance. This study aims to train and test the performance of a deep learning model that can identify inappropriate landing zones during endovascular aneurysm repair (EVAR). METHODS A deep learning model was trained to identify a "No-Go" landing zone during EVAR, defined by coverage of the lowest renal artery by the stent graft. Fluoroscopic images from elective EVAR procedures performed at a single institution and from open-access sources were selected. Annotations of the "No-Go" zone were performed by trained annotators. A 10-fold cross-validation technique was used to evaluate the performance of the model against human annotations. Primary outcomes were intersection-over-union (IoU) and F1 score and secondary outcomes were pixel-wise accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). RESULTS The AI model was trained using 369 images procured from 110 different patients/videos, including 18 patients/videos (44 images) from open-access sources. For the primary outcomes, IoU and F1 were 0.43 (standard deviation ± 0.29) and 0.53 (±0.32), respectively. For the secondary outcomes, accuracy, sensitivity, specificity, NPV, and PPV were 0.97 (±0.002), 0.51 (±0.34), 0.99 (±0.001). 0.99 (±0.002), and 0.62 (±0.34), respectively. CONCLUSIONS AI can effectively identify suboptimal areas of stent deployment during EVAR. Further directions include validating the model on datasets from other institutions and assessing its ability to predict optimal stent graft placement and clinical outcomes.
Collapse
Affiliation(s)
- Allen Li
- Faculty of Medicine & The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada
| | - Arshia P Javidan
- Division of Vascular Surgery, University of Toronto, Toronto, Ontario, Canada
| | - Babak Namazi
- Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX
| | - Amin Madani
- Department of Surgery, University Health Network & University of Toronto, Toronto, Ontario, Canada; Surgical Artificial Intelligence Research Academy, University Health Network, Toronto, Ontario, Canada
| | - Thomas L Forbes
- Department of Surgery, University Health Network & University of Toronto, Toronto, Ontario, Canada.
| |
Collapse
|
6
|
Abdullah A, Hamzah A, Alsudais AS, Alzahrani RS, Souror H, Alqarni GS, Ashqar AA, Hemeq YH, Dakkak O. A Global Bibliometric Analysis of the Top 100 Most Cited Articles on Carotid Body Tumors. Cureus 2024; 16:e54754. [PMID: 38524015 PMCID: PMC10961149 DOI: 10.7759/cureus.54754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/23/2024] [Indexed: 03/26/2024] Open
Abstract
The carotid body, situated at the common carotid artery bifurcation, comprises specialized glomus cells responsible for sensing blood oxygen, carbon dioxide, pH, and temperature changes, crucial for regulating breathing and maintaining oxygen homeostasis. Carotid body tumors (CBTs), arising from these cells, are rare, representing only 0.5% of head and neck tumors, often presenting as benign, slow-growing, vascularized masses. In February 2023, this bibliometric analysis was conducted, which involved screening 1733 articles from the Web of Science database. The screening process was based on citation count, and articles were selected for inclusion based on specific criteria that focused on CBTs located within the carotid bifurcation. Rigorous selection involved independent screening and data extraction by four authors. The top 100 articles, published between 1948 and 2019, totaled 6623 citations and were authored by 98 unique first authors from 22 countries and 77 institutions, spanning 42 journals. Treatment articles were the predominant category, comprising 49% of the literature. This analysis offers insights into publication trends, identifies literature gaps, and outlines areas of research focus, providing a valuable resource to guide future studies on CBTs.
Collapse
Affiliation(s)
- Abdullah Abdullah
- Department of Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, SAU
| | - Abdulaziz Hamzah
- College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, SAU
- Department of Research, King Abdullah International Medical Research Center, Jeddah, SAU
| | - Ali S Alsudais
- College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, SAU
- Department of Research, King Abdullah International Medical Research Center, Jeddah, SAU
| | - Raghad S Alzahrani
- College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, SAU
- Department of Research, King Abdullah International Medical Research Center, Jeddah, SAU
| | - Hatem Souror
- College of Medicine, University of Jeddah, Jeddah, SAU
| | | | - Afnan A Ashqar
- College of Medicine, Batterjee Medical College, Jeddah, SAU
| | - Yousef H Hemeq
- College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, SAU
- Department of Research, King Abdullah International Medical Research Center, Jeddah, SAU
| | - Omar Dakkak
- Department of Surgery (Vascular Surgery), International Medical Center Hospital, Jeddah, SAU
| |
Collapse
|
7
|
Shiferaw KB, Wali P, Waltemath D, Zeleke AA. Navigating the AI frontiers in cardiovascular research: a bibliometric exploration and topic modeling. Front Cardiovasc Med 2024; 10:1308668. [PMID: 38235288 PMCID: PMC10793658 DOI: 10.3389/fcvm.2023.1308668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2023] [Accepted: 12/04/2023] [Indexed: 01/19/2024] Open
Abstract
Artificial intelligence (AI) has emerged as a promising field in cardiovascular disease (CVD) research, offering innovative approaches to enhance diagnosis, treatment, and patient outcomes. In this study, we conducted bibliometric analysis combined with topic modeling to provide a comprehensive overview of the AI research landscape in CVD. Our analysis included 23,846 studies from Web of Science and PubMed, capturing the latest advancements and trends in this rapidly evolving field. By employing LDA (Latent Dirichlet Allocation) we identified key research themes, trends, and collaborations within the AI-CVD domain. The findings revealed the exponential growth of AI-related research in CVD, underscoring its immense potential to revolutionize cardiovascular healthcare. The annual scientific publication of machine learning papers in CVD increases continuously and significantly since 2016, with an overall annual growth rate of 22.8%. Almost half (46.2%) of the growth happened in the last 5 years. USA, China, India, UK and Korea were the top five productive countries in number of publications. UK, Germany and Australia were the most collaborative countries with a multiple country publication (MCP) value of 42.8%, 40.3% and 40.0% respectively. We observed the emergence of twenty-two distinct research topics, including "stroke and robotic rehabilitation therapy," "robotic-assisted cardiac surgery," and "cardiac image analysis," which persisted as major topics throughout the years. Other topics, such as "retinal image analysis and CVD" and "biomarker and wearable signal analyses," have recently emerged as dominant areas of research in cardiovascular medicine. Convolutional neural network appears to be the most mentioned algorithm followed by LSTM (Long Short-Term Memory) and KNN (K-Nearest Neighbours). This indicates that the future direction of AI cardiovascular research is predominantly directing toward neural networks and image analysis. As AI continues to shape the landscape of CVD research, our study serves as a comprehensive guide for researchers, practitioners, and policymakers, providing valuable insights into the current state of AI in CVD research. This study offers a deep understanding of research trends and paves the way for future directions to maximiz the potential of AI to effectively combat cardiovascular diseases.
Collapse
Affiliation(s)
- Kirubel Biruk Shiferaw
- Department of Medical Informatics, Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
| | | | | | | |
Collapse
|
8
|
Javidan A, Benipal H, Vi L, Li A, Lee Y, Feridooni T, Alaichi J, Naji F. Assessing the robustness of positive vascular surgery randomized controlled trials using their fragility index. J Vasc Surg 2024; 79:148-158.e3. [PMID: 37315910 DOI: 10.1016/j.jvs.2023.05.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2021] [Revised: 05/15/2023] [Accepted: 05/17/2023] [Indexed: 06/16/2023]
Abstract
OBJECTIVE The fragility index (FI) measures the robustness of statistically significant findings in randomized controlled trials (RCTs) by quantifying the minimum number of event conversions required to reverse a dichotomous outcome's statistical significance. In vascular surgery, many clinical guidelines and critical decision-making points are informed by a handful of key RCTs, especially regarding open surgical versus endovascular treatment. The objective of this study is to evaluate the FI of RCTs with statistically significant primary outcomes that compared open vs endovascular surgery in vascular surgery. METHODS In this meta-epidemiological study and systematic review, MEDLINE, Embase, and CENTRAL were searched for RCTs comparing open versus endovascular treatments for abdominal aortic aneurysms, carotid artery stenosis, and peripheral arterial disease to December 2022. RCTs with statistically significant primary outcomes were included. Data screening and extraction were conducted in duplicate. The FI was calculated by adding an event to the group with the smaller number of events while subtracting a nonevent to the same group until Fisher's exact test produced a nonstatistically significant result. The primary outcome was the FI and proportion of outcomes where the loss to follow-up was greater than the FI. The secondary outcomes assessed the relationship of the FI to disease state, presence of commercial funding, and study design. RESULTS Overall, 5133 articles were captured in the initial search with 21 RCTs reporting 23 different primary outcomes being included in the final analysis. The median FI (first quartile, third quartile) was 3 (3, 20) with 16 outcomes (70%) reporting a loss to follow-up greater than its FI. Mann-Whitney U test revealed that commercially funded RCTs and composite outcomes had greater FIs (median, 20.0 [5.5, 24.5] vs median, 3.0 [2.0, 5.5], P = .035; median, 21 [8, 38] vs median, 3.0 [2.0, 8.5], P = .01, respectively). The FI did not vary between disease states (P = .285) or between index and follow-up trials (P = .147). There were significant correlations between the FI and P values (Pearson r = 0.90; 95% confidence interval, 0.77-0.96), and the number of events (r = 0.82; 95% confidence interval, 0.48-0.97). CONCLUSIONS A small number of event conversions (median, 3) are needed to alter the statistical significance of primary outcomes in vascular surgery RCTs evaluating open surgical and endovascular treatments. Most studies had loss to follow-up greater than its FI, which can call into question trial results, and commercially funded studies had a greater FI. The FI and these findings should be considered in future trial design in vascular surgery.
Collapse
Affiliation(s)
- Arshia Javidan
- Division of Vascular Surgery, University of Toronto, Toronto, Ontario, Canada.
| | - Harsukh Benipal
- Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Lisa Vi
- Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Allen Li
- Faculty of Medicine/The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada
| | - Yung Lee
- Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada; Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA
| | - Tiam Feridooni
- Division of Vascular Surgery, University of Toronto, Toronto, Ontario, Canada
| | - Jacob Alaichi
- Division of Vascular Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada
| | - Faysal Naji
- Division of Vascular Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada
| |
Collapse
|
9
|
Asaadi S, Martins KN, Lee MM, Pantoja JL. Artificial intelligence for the vascular surgeon. Semin Vasc Surg 2023; 36:394-400. [PMID: 37863611 DOI: 10.1053/j.semvascsurg.2023.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2023] [Revised: 04/22/2023] [Accepted: 05/24/2023] [Indexed: 10/22/2023]
Abstract
In recent years, artificial intelligence (AI) has permeated different aspects of vascular surgery to solve challenges in clinical practice. Although AI in vascular surgery is still in its early stages, there have been promising developments in its applications to vascular diagnosis, risk stratification, and outcome prediction. By establishing a baseline knowledge of AI, vascular surgeons are better equipped to use and interpret the data from these types of projects. This review aims to provide an overview of the fundamentals of AI and highlight its role in helping vascular surgeons overcome the challenges of clinical practice. In addition, we discuss the limitations of AI and how they affect AI applications.
Collapse
Affiliation(s)
- Sina Asaadi
- Veterans Administration Loma Linda Healthcare System, 11201 Benton Street, Mail Code 112, Loma Linda, CA 92357
| | | | - Mary M Lee
- Veterans Administration Loma Linda Healthcare System, 11201 Benton Street, Mail Code 112, Loma Linda, CA 92357
| | - Joe Luis Pantoja
- Veterans Administration Loma Linda Healthcare System, 11201 Benton Street, Mail Code 112, Loma Linda, CA 92357.
| |
Collapse
|
10
|
Stonko DP, Hicks CW. Mature artificial intelligence- and machine learning-enabled medical tools impacting vascular surgical care: A scoping review of late-stage, US Food and Drug Administration-approved or cleared technologies relevant to vascular surgeons. Semin Vasc Surg 2023; 36:460-470. [PMID: 37863621 PMCID: PMC10589449 DOI: 10.1053/j.semvascsurg.2023.06.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2023] [Revised: 06/14/2023] [Accepted: 06/20/2023] [Indexed: 10/22/2023]
Abstract
Artificial intelligence and machine learning (AI/ML)-enabled tools are shifting from theoretical or research-only applications to mature, clinically useful tools. The goal of this article was to provide a scoping review of the most mature AI/ML-enabled technologies reviewed and cleared by the US Food and Drug Administration relevant to the field of vascular surgery. Despite decades of slow progress, this landscape is now evolving rapidly, with more than 100 AI/ML-powered tools being approved by the US Food and Drug Administration each year. Within the field of vascular surgery specifically, this review identified 17 companies with mature technologies that have at least one US Food and Drug Administration clearance, all occurring between 2016 and 2022. The maturation of these technologies appears to be accelerating, with improving regulatory clarity and clinical uptake. The early AI/ML-powered devices extend or amplify clinically entrenched platform technologies and tend to be focused on the diagnosis or evaluation of time-sensitive, clinically important pathologies (eg, reading Digital Imaging and Communications in Medicine-compliant computed tomography images to identify pulmonary embolism), or when physician efficiency or time savings is improved (eg, preoperative planning and intraoperative guidance). The majority (>75%) of these technologies are at the intersection of radiology and vascular surgery. It is becoming increasingly important that the contemporary vascular surgeon understands this shifting paradigm, as these once-nascent technologies are finally maturing and will be encountered with increasingly regularity in daily clinical practice.
Collapse
Affiliation(s)
- David P Stonko
- Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, The Johns Hopkins Hospital, 600 North Wolfe Street, Halsted 668, Baltimore, MD 21287
| | - Caitlin W Hicks
- Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, The Johns Hopkins Hospital, 600 North Wolfe Street, Halsted 668, Baltimore, MD 21287.
| |
Collapse
|
11
|
Tran Z, Byun J, Lee HY, Boggs H, Tomihama EY, Kiang SC. Bias in artificial intelligence in vascular surgery. Semin Vasc Surg 2023; 36:430-434. [PMID: 37863616 DOI: 10.1053/j.semvascsurg.2023.07.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Revised: 07/28/2023] [Accepted: 07/28/2023] [Indexed: 10/22/2023]
Abstract
Application of artificial intelligence (AI) has revolutionized the utilization of big data, especially in patient care. The potential of deep learning models to learn without a priori assumption, or without prior learning, to connect seemingly unrelated information mixes excitement alongside hesitation to fully understand AI's limitations. Bias, ranging from data collection and input to algorithm development to finally human review of algorithm output affects AI's application to clinical patient presents unique challenges that differ significantly from biases in traditional analyses. Algorithm fairness, a new field of research within AI, aims to mitigate bias by evaluating the data at the preprocessing stage, optimizing during algorithm development, and evaluating algorithm output at the postprocessing stage. As the field continues to develop, being cognizant of the inherent biases and limitations related to black box decision making, biased data sets agnostic to patient-level disparities, wide variation of present methodologies, and lack of common reporting standards will require ongoing research to provide transparency to AI and its applications.
Collapse
Affiliation(s)
- Zachary Tran
- Department of Surgery, Division of Vascular Surgery, Linda University School of Medicine, 11175 Campus Street, Suite 21123, Loma Linda, CA 92350
| | - Julianne Byun
- Department of Surgery, Division of Vascular Surgery, Linda University School of Medicine, 11175 Campus Street, Suite 21123, Loma Linda, CA 92350
| | - Ha Yeon Lee
- Department of Surgery, Division of Vascular Surgery, Linda University School of Medicine, 11175 Campus Street, Suite 21123, Loma Linda, CA 92350
| | - Hans Boggs
- Department of Surgery, Division of Vascular Surgery, Linda University School of Medicine, 11175 Campus Street, Suite 21123, Loma Linda, CA 92350
| | - Emma Y Tomihama
- Department of Surgery, Division of Vascular Surgery, Linda University School of Medicine, 11175 Campus Street, Suite 21123, Loma Linda, CA 92350
| | - Sharon C Kiang
- Department of Surgery, Division of Vascular Surgery, Linda University School of Medicine, 11175 Campus Street, Suite 21123, Loma Linda, CA 92350; Department of Surgery, Division of Vascular Surgery, VA Loma Linda Healthcare System, 11201 Benton Street, Loma Linda, CA 92357.
| |
Collapse
|
12
|
Lareyre F, Wanhainen A, Raffort J. Artificial Intelligence-Powered Technologies for the Management of Vascular Diseases: Building Guidelines and Moving Forward Evidence Generation. J Endovasc Ther 2023:15266028231187599. [PMID: 37464795 DOI: 10.1177/15266028231187599] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/20/2023]
Affiliation(s)
- Fabien Lareyre
- Department of Vascular Surgery, Hospital of Antibes Juan-les-Pins, Antibes, France
- Université Côte d'Azur, Inserm U1065, C3M, Nice, France
| | - Anders Wanhainen
- Section of Vascular Surgery, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
- Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden
| | - Juliette Raffort
- Université Côte d'Azur, Inserm U1065, C3M, Nice, France
- 3IA Institute, Université Côte d'Azur, Nice, France
- Department of Clinical Biochemistry, University Hospital of Nice, Nice, France
| |
Collapse
|
13
|
Titov O, Bykanov A, Pitskhelauri D. Neurosurgical skills analysis by machine learning models: systematic review. Neurosurg Rev 2023; 46:121. [PMID: 37191734 DOI: 10.1007/s10143-023-02028-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2023] [Revised: 04/16/2023] [Accepted: 05/06/2023] [Indexed: 05/17/2023]
Abstract
Machine learning (ML) models are being actively used in modern medicine, including neurosurgery. This study aimed to summarize the current applications of ML in the analysis and assessment of neurosurgical skills. We conducted this systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched the PubMed and Google Scholar databases for eligible studies published until November 15, 2022, and used the Medical Education Research Study Quality Instrument (MERSQI) to assess the quality of the included articles. Of the 261 studies identified, we included 17 in the final analysis. Studies were most commonly related to oncological, spinal, and vascular neurosurgery using microsurgical and endoscopic techniques. Machine learning-evaluated tasks included subpial brain tumor resection, anterior cervical discectomy and fusion, hemostasis of the lacerated internal carotid artery, brain vessel dissection and suturing, glove microsuturing, lumbar hemilaminectomy, and bone drilling. The data sources included files extracted from VR simulators and microscopic and endoscopic videos. The ML application was aimed at classifying participants into several expertise levels, analysis of differences between experts and novices, surgical instrument recognition, division of operation into phases, and prediction of blood loss. In two articles, ML models were compared with those of human experts. The machines outperformed humans in all tasks. The most popular algorithms used to classify surgeons by skill level were the support vector machine and k-nearest neighbors, and their accuracy exceeded 90%. The "you only look once" detector and RetinaNet usually solved the problem of detecting surgical instruments - their accuracy was approximately 70%. The experts differed by more confident contact with tissues, higher bimanuality, smaller distance between the instrument tips, and relaxed and focused state of the mind. The average MERSQI score was 13.9 (from 18). There is growing interest in the use of ML in neurosurgical training. Most studies have focused on the evaluation of microsurgical skills in oncological neurosurgery and on the use of virtual simulators; however, other subspecialties, skills, and simulators are being investigated. Machine learning models effectively solve different neurosurgical tasks related to skill classification, object detection, and outcome prediction. Properly trained ML models outperform human efficacy. Further research on ML application in neurosurgery is needed.
Collapse
Affiliation(s)
- Oleg Titov
- Burdenko Neurosurgery Center, Moscow, Russia.
- OPEN BRAIN, Laboratory of Neurosurgical Innovations, Moscow, Russia.
| | | | | |
Collapse
|
14
|
Lareyre F, Behrendt CA, Chaudhuri A, Raffort J. Artificial Intelligence in Vascular Surgical Departments: Slowly But Surely. Angiology 2023; 74:399-400. [PMID: 36042693 DOI: 10.1177/00033197221124759] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Fabien Lareyre
- Department of Vascular Surgery, 70607Hospital of Antibes, Juan-les-Pins, France.,Université Côte d'Azur, 477107Inserm U1065, C3M, France
| | - Christian-Alexander Behrendt
- 575329Brandenburg Medical School Theodor-Fontane, Neuruppin, Germany.,Research Group GermanVasc, 06000University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.,Department of Vascular and Endovascular Surgery, Asklepios Clinic Wandsbek, 477107Asklepios Medical School Hamburg, Germany
| | - Arindam Chaudhuri
- Bedfordshire - Milton Keynes Vascular Centre, 575329Bedfordshire Hospitals NHS Foundation Trust, UK
| | - Juliette Raffort
- Université Côte d'Azur, 477107Inserm U1065, C3M, France.,Department of Clinical Biochemistry, University Hospital of Nice, France.,3IA Institute, Université Côte d'Azur, Sophia Antipolis, France
| |
Collapse
|
15
|
Shaikh AK, Alhashmi SM, Khalique N, Khedr AM, Raahemifar K, Bukhari S. Bibliometric analysis on the adoption of artificial intelligence applications in the e-health sector. Digit Health 2023; 9:20552076221149296. [PMID: 36683951 PMCID: PMC9850136 DOI: 10.1177/20552076221149296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2022] [Accepted: 12/18/2022] [Indexed: 01/19/2023] Open
Abstract
Artificial Intelligent (AI) applications in e-health have evolved considerably in the last 25 years. To track the current research progress in this field, there is a need to analyze the most recent trend of adopting AI applications in e-health. This bibliometric analysis study covers AI applications in e-health. It differs from the existing literature review as the journal articles are obtained from the Scopus database from its beginning to late 2021 (25 years), which depicts the most recent trend of AI in e-health. The bibliometric analysis is employed to find the statistical and quantitative analysis of available literature of a specific field of study for a particular period. An extensive global literature review is performed to identify the significant research area, authors, or their relationship through published articles. It also provides the researchers with an overview of the work evolution of specific research fields. The study's main contribution highlights the essential authors, journals, institutes, keywords, and states in developing the AI field in e-health.
Collapse
Affiliation(s)
| | - Saadat M Alhashmi
- Department of Information Systems, College of Computing and
Informatics, University of
Sharjah, Sharjah, United Arab
Emirates,Saadat M Alhashmi, University of Sharjah,
College of Computing and Informatics, College of Computing and Informatics,
University of Sharjah, Sharjah 27272, United Arab Emirates.
| | - Nadia Khalique
- College of
Economics and Political Science, Sultan Qaboos
University, Muscat, Oman
| | - Ahmed M. Khedr
- Department of Information Systems, College of Computing and
Informatics, University of
Sharjah, Sharjah, United Arab
Emirates
| | | | - Sadaf Bukhari
- Beijing
Institute of Technology, Beijing, Beijing,
China
| |
Collapse
|
16
|
Assessing the robustness of negative vascular surgery randomized controlled trials using their reverse fragility index. J Vasc Surg 2022:S0741-5214(22)02650-7. [PMID: 36572321 DOI: 10.1016/j.jvs.2022.12.029] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2022] [Revised: 12/15/2022] [Accepted: 12/17/2022] [Indexed: 12/25/2022]
Abstract
OBJECTIVE The reverse fragility index (RFI) describes the number of event conversions needed to convert a statistically nonsignificant dichotomous outcome to a significant one. The objective of the present study was to assess the RFI of vascular surgery randomized controlled trials (RCTs) comparing endovascular vs open surgery for the treatment of abdominal aortic aneurysms (AAAs), carotid artery stenosis (CAS), and peripheral artery disease (PAD). METHODS MEDLINE and Embase were searched for RCTs that had investigated AAAs, CAS, or PAD with statistically nonsignificant binary primary outcomes. The primary outcome for the present study was the median RFI. Calculation of the RFI was performed by creating two-by-two contingency tables and subtracting events from the group with fewer events and adding nonevents to the same group until a two-tailed Fisher exact test had produced a statistically significant result (P ≤ .05). RESULTS Of 4187 reports, 49 studies reporting 103 different primary end points were included. The overall median RFI was 7 (interquartile range [IQR], 5-13). The specific RFIs for AAA, CAS, and PAD were 10 (IQR, 6-15.5), 6 (IQR, 5-9.5), and 7 (IQR, 5.5-10), respectively. Of the 103 end points, 42 (47%) had had a loss to follow-up greater than the RFI, of which 10 were AAA trials (24%), 23 were CAS trials (55%), and 9 were PAD trials (21%). The Pearson correlation demonstrated a significant positive relationship between a study's RFI and the impact factor of its publishing journal (r = 0.38; 95% confidence interval [CI], 0.20-0.54; P < .01), length of follow-up (r = 0.43; 95% CI, 0.26-0.58; P < .01), and sample size (r = 0.28; 95% CI, 0.09-0.45; P < .01). CONCLUSIONS A small number of events (median, 7) was required to change the outcome of negative RCTs from statistically nonsignificant to significant, with 47% of the studies having missing data that could have reversed the finding of its primary outcome. Reporting of the RFI relative to the loss to follow-up could be of benefit in future trials and provide confidence regarding the robustness of the P value.
Collapse
|
17
|
Lareyre F, Lê CD, Adam C, Carrier M, Raffort J. Bibliometric Analysis on Artificial Intelligence and Machine Learning in Vascular Surgery. Ann Vasc Surg 2022; 86:e1-e2. [PMID: 35798225 DOI: 10.1016/j.avsg.2022.06.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Accepted: 06/02/2022] [Indexed: 12/17/2022]
Affiliation(s)
- Fabien Lareyre
- Department of Vascular Surgery, Hospital of Antibes Juan-les-Pins, Antibes, France; Université Côte d'Azur, Inserm U1065, C3M, Nice, France.
| | - Cong Duy Lê
- Department of Vascular Surgery, Hospital of Antibes Juan-les-Pins, Antibes, France; Université Côte d'Azur, Inserm U1065, C3M, Nice, France
| | - Cédric Adam
- Laboratory of Applied Mathematics and Computer Science (MICS), CentraleSupélec, Université Paris-Saclay, Paris, France
| | - Marion Carrier
- Laboratory of Applied Mathematics and Computer Science (MICS), CentraleSupélec, Université Paris-Saclay, Paris, France
| | - Juliette Raffort
- Université Côte d'Azur, Inserm U1065, C3M, Nice, France; Clinical Chemistry Laboratory, University Hospital of Nice, Nice, France; 3IA Institute, Université Côte d'Azur, Sophia-Antipolis, France
| |
Collapse
|